Novavax

US · NVAX #2865 by market cap Listed 1970

11.22 -0.10 -0.88%

Live - 5344 symbols - heartbeat 426s ago · 2026-10-08 06:47

Pre-market 11.06 -1.46%

After-hours 11.16 -0.53%

Overnight 11.03 -1.69%

Market cap: 1.85B
P/E (TTM): -8.31
P/B: -9.71
EPS: 2.58
Div yield: 0.00%
52W pos: 70%

Reader sentiment Are you bullish or bearish on NVAX?

Anonymous reader poll. Unscientific, not investment advice.

About Novavax

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Founded: 1987
CEO: Mr. John C. Jacobs
Employees: 749
Headquarters: Gaithersburg, Maryland, United States of America
Fiscal year end: 12-31
Website: novavax.com

Company profile

Exchange: US
Symbol: NVAX
Market-cap rank: #2865
Listing date: 1970-01-01
Market cap: 1.85B
Float cap: 1.60B
Shares out: 164.95M
Float shares: 142.58M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 06:47:28 · For reference only, not investment advice and not tailored to your situation.